Vimarsana
Biggest News Aggregation in the World

Page 2 - Technology Assessment Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Assessment Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Assessment Program Today - Breaking & Trending Today

Pediatric CAP: Lower-Dose, Shorter Duration Amoxicillin Effective in Study - Vimarsana News

Pediatric CAP: Lower-Dose, Shorter Duration Amoxicillin Effective in Study

Trial finds 3 days of lower dose noninferior to higher-dose, 7 day regimen Although amoxicillin is widely recognized for treatment of community acquired pneumonia (CAP) in young children, the optimal dose and optimal duration of therapy remain unclear, as neither have been widely studied. For example, in 2011 the Infectious Diseases Society of America recommended

Komline-Sanderson Acquires AquaShield To Offer Stormwater Products - Vimarsana News

Komline-Sanderson Acquires AquaShield To Offer Stormwater Products

Komline-Sanderson, a designer and manufacturer of equipment for wastewater management, environmental control, and other industrial applications,...

Covid vaccine progress needs investment - Vimarsana News

Covid vaccine progress needs investment

Covid vaccine progress needs investment 4 4 In normal times, a vaccine is a health product that works its way to protect a person from a disease. But in the age of "new normal", vaccines can define a country's development level. Advanced countries such as the US and UK started rolling out vaccination programmes last month as authorised agencies approved Pfizer's and Moderna's vaccine for emergency use, while developing countries have to wait longer as available vaccines of the two pharma giants are mostly reserved. Thailand is likely to get vaccines from AstraZeneca, a British-Swedish pha...